Table 2 Prevalence of postnatal congenital heart disease and prenatal haemodynamic findings.
| Abnormal finding | Present | Absent | p Value | ||
|---|---|---|---|---|---|
| Prenatally | Postnatally | Prenatally | Postnatally | ||
| Recipients | |||||
| DVnegA | 16 | 3 (18.8%) | 35 | 4 (11.4%) | 0.66 |
| TR | 26 | 5 (19.2%) | 25 | 2 (8.0%) | 0.42 |
| MR | 7 | 2 (28.6%) | 44 | 5 (11.4%) | 0.24 |
| Hydrops | 3 | 0 | 48 | 7 (14.6%) | 1.00 |
| Donors | |||||
| UAEDFneg | 9 | 1 (11.2%) | 29 | 2 (6.9%) | 1.00 |
Fisher's exact test showed no significant differences in the prevalence of congenital heart disease in babies with and without abnormal prenatal haemodynamic findings. Significance was considered for p<0.05.
DVnegA, ductus venosus negative A wave (absent or reversed flow during atrial contraction); MR, mitral regurgitation; TR, tricuspid regurgitation; UAEDFneg, umbilical artery end diastolic flow absent or reversed.